Informa (LON:INF) Price Target Raised to GBX 1,000

Informa (LON:INF) had its target price upped by Citigroup from GBX 975 to GBX 1,000 in a report released on Thursday, MarketBeat Ratings reports. The firm currently has a neutral rating on the stock.

INF has been the topic of a number of other reports. JPMorgan Chase & Co. lowered their price objective on Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating on the stock in a research report on Monday, January 12th. UBS Group restated a “buy” rating and set a GBX 1,055 target price on shares of Informa in a research note on Friday, November 7th. Berenberg Bank reiterated a “buy” rating and issued a GBX 1,030 price target on shares of Informa in a research report on Wednesday. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Finally, Panmure Gordon restated a “buy” rating and set a GBX 1,200 price objective on shares of Informa in a research report on Wednesday, November 19th. Six analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of GBX 1,097.86.

Informa Price Performance

LON INF opened at GBX 934.26 on Thursday. The business’s fifty day moving average is GBX 906.04 and its 200 day moving average is GBX 902.87. Informa has a fifty-two week low of GBX 634.20 and a fifty-two week high of GBX 1,000. The company has a debt-to-equity ratio of 31.98, a quick ratio of 1.70 and a current ratio of 0.56. The company has a market capitalization of £11.95 billion, a PE ratio of 169.86, a price-to-earnings-growth ratio of 0.75 and a beta of 1.12.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.